
Masimo has received FDA 510(k) clearance for Root® with LiDCO® and the Masimo LiDCO Sensor, providing the ability to continuously monitor and trend oxygen delivery (DO₂). By combining continuous Masimo SpHb® noninvasive hemoglobin, Masimo SET® oxygen saturation, and cardiac output, the solution provides clinicians with a more complete view of oxygen being delivered to the tissue. Learn more: ow.ly/1iz250ZEZYy #Masimo #LiDCO #PatientMonitoring #Hemodynamics less
















